Clene Inc.
Developing nanocrystal therapies for neurodegenerative diseases like ALS and MS.
CLNN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, 84121 SALT LAKE CITY
- Website:
- https://clene.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Clene Inc. is a clinical-stage biopharmaceutical company dedicated to developing treatments for neurodegenerative diseases. The company utilizes its proprietary nanotherapeutic platform to create clean-surfaced, catalytically-active nanocrystals designed to address cellular energy impairments. By focusing on improving mitochondrial health, Clene aims to restore and protect neuronal function in patients with high unmet medical needs. Its pipeline is advancing novel nanotherapeutics, including its lead candidate CNM-Au8, for diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Clene Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Clene Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Clene Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
